At-Home Self-Collection Device for Cervical Cancer Screening Gets FDA Approval
Teal Health has received FDA approval for the Teal Wand, a prescription-based self-collection device for cervical cancer screening.
Read MorePosted by Chris Wolski | May 12, 2025 | Cervical (HPV) |
Teal Health has received FDA approval for the Teal Wand, a prescription-based self-collection device for cervical cancer screening.
Read MorePosted by Chris Wolski | May 12, 2025 | Gastrointestinal Infections |
Researchers are uncovering how the deadly parasite E. histolytica kills human cells and evades the immune system.
Read MorePosted by Chris Wolski | May 9, 2025 | Immunoassay Reagents & test Kits |
ALPCO has launched its FDA-cleared Calprotectin Immunoturbidimetric Assay in Europe and begun a pivotal U.S. clinical trial.
Read MorePosted by Chris Wolski | May 8, 2025 | Diabetes & Metabolic Diseases |
Nordic Bioscience’s PRO-C3 test, now launched globally by Roche Diagnostics on cobas analyzers, offers a way to assess liver fibrosis.
Read MorePosted by Chris Wolski | May 7, 2025 | Cancer |
New predictive algorithms using routine health data and blood tests significantly improve early detection of 15 cancers.
Read More